Transpharmation Ltd.
Colleen Taylor is the Director and Head of Operations at Transpharmation Ltd. since January 2011, overseeing the UK lab team at RVC and Imperial College and leading the establishment of new labs at Discovery Park in Sandwich. Prior to this role, Colleen served as a Principal Scientist at GSK from May 2000 to August 2010, focusing on gastrointestinal research. Colleen holds a degree from the University of Westminster, obtained between 1996 and 1999.
This person is not in any teams
Transpharmation Ltd.
Transpharmation is a contract research organisation led by scientists. As the largest boutique Neuroscience-specialised small and large animal CRO, we can connect drug developers with world-leading technology platforms. Recognised by drug developers worldwide for researching and delivering life-changing medicines, science will always remain our passion. Our clients benefit from decades of experience in cross-species and cross-therapeutic area translational biology throughout our preclinical services. Success is measured by results and driven by a desire to make a difference. Our breadth of neuroscience expertise means clients are able to benchmark their compounds against clinical gold standards in well validated behavioural and molecular assays. Whether you are interested in pain models, sleep models or anything in between, please don’t hesitate to contact us. We are committed to on-time data delivery and flexibility in deal structuring for your project. As such we will work alongside you in collaborative research, via contract work or in a full-time capacity, wherever you are around the globe. NEW! Transpharmation and InterVivo Solutions have united to form the largest boutique Neuroscience-specialised small and large animal CRO. Transpharmation’s Facilities Management Company, Agenda Life Sciences, are one of only 14 establishments to hold the globally recognised AAALAC accreditation assuring clients of scientific validity and reliable, robust scientific outcomes.